No increased risk of fatal CV events for breast cancer patients on newer hormone therapy
In a new study from Kaiser Permanente, researchers found the use of aromatase inhibitors, hormone-therapy drugs used to treat patients with breast cancer, was not associated with an increased risk of fatal cardiovascular ...
Apr 21, 2016
0
2